课题基金 / 基金详情

QUINOLINIC ACID AS BIOMARKER OF SIV INFECTION & SAIDS: CNS

QUINOLINIC ACID AS BIOMARKER OF SIV INFECTION & SAIDS: CNS
喹啉酸作为 SIV 感染的生物标志物
批准号:
6277649
负责人:
CHRISTOPHER L COE
金额:
$10.51万
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-05-01 至 1999-04-30

项目摘要

项目成果

CHRISTOPHER L COE的其他基金

相似基金

相关文献

中文摘要
翻译
前言:目的:评价我国喹啉酸生产的变化情况。 对病毒感染和疾病进展的反应。结果 之前我们证明了神经毒素,喹啉酸,是 体循环和鞘内间隙均增加 在逆转录病毒感染之后。我们现在已经开始调查 中枢神经系统内Quin的潜在来源。中枢神经系统内的Quin可能 源于血脑屏障的扩散,或可能反映 与中枢神经系统有关的细胞内源性产生 单核/巨噬细胞谱系。以前收集的冷冻尸检 来自受感染动物的组织样本正在进行分析,以确定 奎宁在大脑中的区域分布。未来方向 未来的一个方向是测试NMDA的有效性 受体拮抗剂阻断奎宁对神经的不良影响 组织。关键词喹啉酸、血脑屏障、猿猴 免疫缺陷病毒,脑脊液NIMH MH41659
英文摘要
OBJECTIVE: To evaluate changes in quinolinic acid production in response to viral infection and disease progression. RESULTS Previously we demonstrated that the neurotoxin, quinolinic acid, is increased in both systemic circulation and the intrathecal compartment following retroviral infection. We have now begun to investigate the potential sources of QUIN within the CNS. QUIN within the CNS may derive from diffusion across the blood-brain-barrier or may reflect endogenous production with the CNS by cells related to the monocyte/macrophage lineage. Previously collected, frozen postmortem tissue samples from infected animals are being analyzed to determine the regional distribution of QUIN within the brain. FUTURE DIRECTIONS One future direction would be to test the effectiveness of NMDA receptor antagonists in blocking the adverse effects of QUIN on neural tissue. KEY WORDS quinolinic acid, blood-brain-barrier, simian immunodeficiency virus, cerebrospinal fluid NIMH MH41659
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection and Correction of Iron Deficiency Induced Abnormal Brain Metabolism
  • 批准号:
    9568365
  • 项目类别:
  • 资助金额:
    $55.7万
  • 财政年份:
    2017
  • 负责人:
    CHRISTOPHER L COE
  • 依托单位:
Detection and Correction of Iron Deficiency Induced Abnormal Brain Metabolism
  • 批准号:
    10190978
  • 项目类别:
  • 资助金额:
    $53.5万
  • 财政年份:
    2017
  • 负责人:
    CHRISTOPHER L COE
  • 依托单位:
Core B -- BioCore
  • 批准号:
    10559174
  • 项目类别:
  • 资助金额:
    $63.88万
  • 财政年份:
    2016
  • 负责人:
    CHRISTOPHER L COE
  • 依托单位:
Early Life Stress and Immune Dysfunction in Post-Institutionalized Adolescents
  • 批准号:
    9229564
  • 项目类别:
  • 资助金额:
    $19.1万
  • 财政年份:
    2016
  • 负责人:
    CHRISTOPHER L COE
  • 依托单位:
海外基金